Publikationen der ALS-Forschungsgruppe an der Charité Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online StudyMaier A, Eicher C, Kiselev J, Mehr Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational studyMeyer T, Spittel S, Grehl T, Mehr Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational studyMaier A, Gaudlitz M, Grehl T, Mehr Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational study Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in GermanySpittel S, Maier A, Kettemann D, Mehr Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programmeMeyer T, Kettemann D, Maier A, Mehr Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spastic using tetrahydrocannabinol:cannabidiol (THC:CBD)Meyer T, Funke A, Münch C, Mehr Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spastic using tetrahydrocannabinol:cannabidiol (THC:CBD) 1 2 3 … 5 Weiter » Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisLudolph AC, Dorst J, Dreyhaupt J, Mehr Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis Prognostic factors in ALS: a comparison between Germany and ChinaDorst J, Chen L, Rosenbohm A, Mehr Prognostic factors in ALS: a comparison between Germany and China GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosisSchumacher H, Meyer T, Prüss H. Mehr GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialLudolph AC, Schuster J, Dorst J, Mehr Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial Comprehensive analysis of the mutation spectrum in 301 German ALS familiesMüller K, Brenner D, Weydt P, Mehr Comprehensive analysis of the mutation spectrum in 301 German ALS families Therapeutic decision in ALS patients: cross-cultural differences and clinical implicationsAndersen PM, Kuzma-Kozakiewicz M, Keller J, Mehr Therapeutic decision in ALS patients: cross-cultural differences and clinical implications 1 2 3 … 8 Weiter »
